Fintel reports that on October 30, 2026, TD Cowen downgraded their outlook for Boston Scientific (BMV:BSX) from Buy to Hold. This rating action follows a prior action by TD Cowen on August 25, 2026, ...
Original Image Link
Source:www.msn.com
Original Image Link
Source:www.msn.com
Posted: 2026-10-30 11:14:46









